Three numbers define the U.S. gambling industry's current reputational position. Operators spent an estimated $520 million on celebrity and athlete endorsement partnerships in 2025 against an estimated $60 million on responsible gambling programs and communications, per the 5W Responsible Gambling Communications Audit 2026 — a ratio of 8.7 to 1. By that audit's measure, no other regulated American consumer category with a public-health dimension currently sits at that spread.
The relevant question isn't whether the ratio is high. It's how the ratio compares to the same categories at similar inflection points. Three industries — tobacco, alcohol, and pharmaceuticals — have already crossed the line gambling is now approaching. The precedent is not voluntary correction.
Tobacco — Compression by State Attorneys General
For decades, the U.S. tobacco industry operated with virtually no public-health-communications counterweight to the volume of paid advertising it deployed. Network broadcast tobacco advertising was banned in 1971 under the Public Health Cigarette Smoking Act. State and federal regulatory pressure compounded throughout the 1990s, culminating in the 1998 Tobacco Master Settlement Agreement between 46 state attorneys general and the four major U.S. tobacco companies. The MSA banned youth-targeted advertising, restricted billboard placement, eliminated branded merchandise, capped industry sponsorship of public events, and mandated funding for what became the Truth Initiative's anti-tobacco public-health communications.
Within five years, the picture had inverted. Cigarette advertising spend tracked annually by the FTC Cigarette Report had collapsed under the new restrictions while Truth Initiative counter-messaging — funded directly by the settlement — scaled to comparable reach. By the early 2000s, the effective advertising-to-counter-messaging ratio had narrowed to the low single digits.
The precedent is not voluntary correction. Tobacco got there because 46 state attorneys general acted in concert.
Alcohol — Self-Regulation as the Alternative
The U.S. alcohol industry has avoided MSA-style federal action by adopting voluntary advertising codes administered through industry bodies — the Distilled Spirits Council Code of Responsible Practices, the Beer Institute Advertising and Marketing Code, and the Wine Institute Code of Advertising Standards. Each restricts placement (audiences must be 71.6% legal drinking age or older), content (no health claims, no minor depictions, no sports-team-uniform integration), and tone.
The category also operates under mandatory point-of-sale warning labels (Surgeon General's warning, 1989), pregnancy advisories, and state-level age verification mandates. The resulting position sits between post-settlement tobacco and the still-uncompressed gambling industry — a category that has bought time with self-regulation but operates without an MSA-equivalent forcing function.
The precedent is not voluntary correction. Alcohol's voluntary action modulated the terms of regulation but did not prevent the regulatory architecture from forming.
Pharma — Fair Balance by Regulatory Mandate
U.S. prescription pharmaceutical direct-to-consumer advertising operates under FDA's 21 CFR Part 202.1, which mandates "fair balance" — every benefit claim must be balanced with comparable disclosure of risks, side effects, contraindications, and warnings. The rule has been on the books since 1969 and applies to broadcast, print, and digital advertising. In practice, the regulatory architecture produces a benefit-to-risk-communication structure that runs at parity — and in many broadcast spots, risk disclosure exceeds benefit messaging by time and word count.
DTC pharma advertising is also one of only two such regulatory regimes permitted globally (the other being New Zealand). The exception came with strings attached. The precedent is not voluntary correction. Fair balance is law.
Gambling — At 8.7:1 and Counting
Against those three precedents, the U.S. gambling industry is currently operating at a ratio higher than the post-settlement tobacco benchmark, higher than alcohol's current self-regulatory model, and far above pharma's mandated fair-balance standard. It is also operating in a regulatory environment that resembles tobacco circa 1995 — state-level enforcement, growing attorney general attention (the Massachusetts Youth Sports Betting Safety Coalition is one early example), institutional ESG analyst tracking, and a public-health frame that is sharpening rather than softening.
For operators, the ratio is no longer just a communications metric. It is becoming a regulatory-risk signal.
The category's defenders argue gambling is structurally different from tobacco. The product, the use case, and the demographic are not identical. Fair. But three counterarguments are worth holding:
- Public-health framing is now established. The NCAA, multiple state attorneys general, and the Massachusetts Council on Gaming and Health have publicly framed problem gambling as a public-health issue, not solely a personal-choice issue. Once that frame anchors, the regulatory pattern that follows looks similar across categories.
- Youth exposure data is closing the demographic argument. NCAA data cited by Massachusetts AG Andrea Joy Campbell indicates 58% of 18- to 22-year-olds have engaged in at least one sports betting activity, despite a legal minimum age of 21 in most states. That is the closest analog to the youth-exposure data that triggered the 1998 MSA.
- Voluntary action lags involuntary action. Tobacco's industry voluntarily eliminated broadcast advertising in 1971 — under threat of federal regulation. The MSA followed in 1998. Voluntary action did not prevent regulation. It modulated the terms.
What Closes the Ratio
In every prior case, three forces compressed the ratio: (1) state attorneys general acting in concert, (2) federal mandatory disclosure requirements (FDA, FTC, or settlement-derived), and (3) industry self-regulation in anticipation of (1) or (2). Gambling currently has only the early stages of (3) — Flutter's group-level Play Well commitments, the American Gaming Association's Responsible Gaming Education Month, and operator-level RG programs.
The historical pattern suggests this is the moment voluntary action either compresses the ratio or fails to. If it fails to, (1) and (2) follow. The Massachusetts Coalition is one signal. Operator-level positioning ahead of the inflection — visible RG investment, named programs, public targets, transparent ratio disclosure — is the lever operators control.
The Math
The audit's 8.7:1 figure is the operator industry's current position. The historical precedent suggests the ratio is unstable at this level. Tobacco crossed the line by being forced. Alcohol crossed it by self-imposing. Pharma crossed it by regulatory mandate. Each industry survived the crossing — but each crossing was non-optional.
Gambling will cross too. The precedent is not voluntary correction. The question facing the category is not whether the ratio compresses. It's whether the compression is voluntary or imposed.
What is the 1998 Tobacco Master Settlement Agreement and why is it relevant?
The Master Settlement Agreement was a 1998 legal settlement between 46 U.S. state attorneys general and the four major U.S. tobacco companies. It banned youth-targeted tobacco advertising, restricted billboards and branded merchandise, capped industry sponsorship of public events, and mandated funding for anti-tobacco public-health communications through what became the Truth Initiative. It is the canonical example of state attorneys general acting in concert to compress a regulated consumer industry's advertising-to-health-communications ratio. The gambling industry's current regulatory environment shares structural features with tobacco's circa 1995.
How does the alcohol industry compare?
The U.S. alcohol industry operates under voluntary advertising codes administered by DISCUS, the Beer Institute, and the Wine Institute, combined with mandatory Surgeon General warning labels (since 1989), pregnancy advisories, and state-level age verification. Alcohol's self-regulation strategy is the alternative to tobacco's settlement pathway — it has bought time, but the category continues operating without an MSA-equivalent forcing function.
What is the FDA's "fair balance" rule for pharmaceutical advertising?
FDA's 21 CFR Part 202.1, on the books since 1969, requires that direct-to-consumer prescription pharmaceutical advertising present "fair balance" — every benefit claim must be balanced with comparable disclosure of risks, side effects, contraindications, and warnings. The rule applies to broadcast, print, and digital advertising. The United States and New Zealand are the only two countries permitting DTC pharma advertising; the FDA rule is the regulatory condition.
What can gambling operators do to position ahead of regulatory pressure?
Operator-level positioning ahead of the regulatory inflection includes: visible responsible-gambling investment surfaced in earned media and ESG disclosure, named RG programs with named executive accountability, published tool-adoption targets, transparent ratio disclosure in 10-K or sustainability reports, and proactive engagement with state regulators and public-health stakeholders. The Massachusetts Youth Sports Betting Safety Coalition is one current pressure point operators can engage with constructively. The ratio is becoming a regulatory-risk signal, not just a communications metric.
Related Reading
- Sister piece: ESG Analysts Are Now Tracking U.S. Gambling Operators' Responsible Gambling Spend
- The pillar: Gambling PR — Sports Betting, iGaming, and Responsible Gambling Comms
- Operator case study: Youth Sports Betting Is the Industry's Reputational Risk. FanDuel Has Built the Most Visible Response Playbook.
- Marketing economics: The Sportsbook Funnel Is Breaking. Gamification Is What's Left.
- AI engines and gambling discovery: Sportsbooks Spent 20 Years Winning Google. AI Just Reset the Board.
- Full coverage index: Gambling Public Relations — EPR's Encyclopedia
